CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market buy Director bought 30,000 shares at $1.55 ($46,404)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, FINANCE AND CAO sold 564 shares at $2.58 ($1,455)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 1,365 shares at $2.58 ($3,522)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 761 shares (to pay taxes)
- 4 Open-market sale PRESIDENT & CSO sold 1,937 shares at $2.58 ($4,997)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 2,191 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $7.90 ($158,076)
- 4 Open-market sale SVP, FINANCE AND CAO sold 1,823 shares at $5.50 ($10,025)
- 4 Open-market sale SVP, FINANCE AND CAO sold 1,373 shares at $5.82 ($7,989)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 3,273 shares at $5.82 ($19,045)
- 4 Open-market sale PRESIDENT & CSO sold 10,758 shares at $5.82 ($62,599)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,789 shares (to pay taxes)
- 4/A Open-market buy CHIEF FINANCIAL OFFICER bought 12,000 shares at $8.53 ($102,338)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 12,000 shares at $8.53 ($102,338)
- 4 Derivatives Options or other derivatives
Page 4 of 11 · 213 filings